Microbial short-chain fatty acids modulate CD8 + T cell responses and improve adoptive immunotherapy for cancer

Published on Jul 1, 2021in Nature Communications14.919
· DOI :10.1038/S41467-021-24331-1
Mark Klein172
Estimated H-index: 172
(University of Mainz)
Sources
Abstract
Emerging data demonstrate that the activity of immune cells can be modulated by microbial molecules. Here, we show that the short-chain fatty acids (SCFAs) pentanoate and butyrate enhance the anti-tumor activity of cytotoxic T lymphocytes (CTLs) and chimeric antigen receptor (CAR) T cells through metabolic and epigenetic reprograming. We show that in vitro treatment of CTLs and CAR T cells with pentanoate and butyrate increases the function of mTOR as a central cellular metabolic sensor, and inhibits class I histone deacetylase activity. This reprogramming results in elevated production of effector molecules such as CD25, IFN-γ and TNF-α, and significantly enhances the anti-tumor activity of antigen-specific CTLs and ROR1-targeting CAR T cells in syngeneic murine melanoma and pancreatic cancer models. Our data shed light onto microbial molecules that may be used for enhancing cellular anti-tumor immunity. Collectively, we identify pentanoate and butyrate as two SCFAs with therapeutic utility in the context of cellular cancer immunotherapy.
📖 Papers frequently viewed together
12 Authors (Si Li, ..., Pin Wang)
20193.24PLOS ONE
13 Authors (Jun Guo, ..., Tzu-Hsuan Huang)
References40
Newest
#2Michael Reiser (Goethe University Frankfurt)H-Index: 1
Last. Zoltán Ivics (Paul Ehrlich Institute)H-Index: 3
view all 10 authors...
Clinical development of chimeric antigen receptor (CAR)-T-cell therapy has been enabled by advances in synthetic biology, genetic engineering, clinical-grade manufacturing, and complex logistics to distribute the drug product to treatment sites. A key ambition of the CARAMBA project is to provide clinical proof-of-concept for virus-free CAR gene transfer using advanced Sleeping Beauty (SB) transposon technology. SB transposition in CAR-T engineering is attractive due to the high rate of stable C...
Source
#1Lukas F. Mager (U of C: University of Calgary)H-Index: 9
#2Regula Burkhard (U of C: University of Calgary)H-Index: 5
Last. Kathy D. McCoy (U of C: University of Calgary)H-Index: 60
view all 13 authors...
Several species of intestinal bacteria have been associated with enhanced efficacy of checkpoint blockade immunotherapy, but the underlying mechanisms by which the microbiome enhances anti-tumor immunity is unclear. Here, we isolated three bacterial species, including Bifidobacterium pseudolongum, Lactobacillus johnsonii and Olsenella species, that significantly enhanced efficacy of immune checkpoint inhibitors in four mouse models of cancer. We found that intestinal B. pseudolongum modulated en...
Source
#1Clélia CoutzacH-Index: 3
#2Jean Mehdi Jouniaux (Université Paris-Saclay)H-Index: 3
Last. Nathalie Chaput (Université Paris-Saclay)H-Index: 46
view all 25 authors...
Gut microbiota composition influences the clinical benefit of immune checkpoints in patients with advanced cancer but mechanisms underlying this relationship remain unclear. Molecular mechanism whereby gut microbiota influences immune responses is mainly assigned to gut microbial metabolites. Short-chain fatty acids (SCFA) are produced in large amounts in the colon through bacterial fermentation of dietary fiber. We evaluate in mice and in patients treated with anti-CTLA-4 blocking mAbs whether ...
Source
#1Teresa Preglej (Medical University of Vienna)H-Index: 5
#2Patricia Hamminger (Medical University of Vienna)H-Index: 5
Last. Wilfried Ellmeier (Medical University of Vienna)H-Index: 38
view all 25 authors...
Some effector CD4+ T cell subsets display cytotoxic activity, thus breaking the functional dichotomy of CD4+ helper and CD8+ cytotoxic T lymphocytes. However, molecular mechanisms regulating CD4+ cytotoxic T lymphocyte (CD4+ CTL) differentiation are poorly understood. Here we show that levels of histone deacetylases 1 and 2 (HDAC1-HDAC2) are key determinants of CD4+ CTL differentiation. Deletions of both Hdac1 and 1 Hdac2 alleles (HDAC1cKO-HDAC2HET) in CD4+ T cells induced a T helper cytotoxic p...
Source
#1Lars WallstabeH-Index: 4
#2Claudia Göttlich (Fraunhofer Society)H-Index: 5
Last. Michael HudecekH-Index: 28
view all 11 authors...
Solid tumors impose immunologic and physical barriers to the efficacy of chimeric antigen receptor (CAR) T cell therapy that are not reflected in conventional preclinical testing against singularized tumor cells in 2-dimensional culture. Here, we established microphysiologic three-dimensional (3D) lung and breast cancer models that resemble architectural and phenotypical features of primary tumors and evaluated the antitumor function of receptor tyrosine kinase–like orphan receptor 1–specific (R...
Source
#1Annabell Bachem (University of Melbourne)H-Index: 9
#2Christina Makhlouf (University of Melbourne)H-Index: 2
Last. Sammy Bedoui (University of Melbourne)H-Index: 35
view all 25 authors...
Interactions with the microbiota influence many aspects of immunity, including immune cell development, differentiation, and function. Here, we examined the impact of the microbiota on CD8+ T cell memory. Antigen-activated CD8+ T cells transferred into germ-free mice failed to transition into long-lived memory cells and had transcriptional impairments in core genes associated with oxidative metabolism. The microbiota-derived short-chain fatty acid (SCFA) butyrate promoted cellular metabolism, en...
Source
#1Katrin MestermannH-Index: 2
#2Theodoros Giavridis (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 6
Last. Michael HudecekH-Index: 28
view all 10 authors...
Immunotherapy with chimeric antigen receptor (CAR)–engineered T cells can be effective against advanced malignancies. CAR T cells are “living drugs” that require technologies to enable physicians (and patients) to maintain control over the infused cell product. Here, we demonstrate that the tyrosine kinase inhibitor dasatinib interferes with the lymphocyte-specific protein tyrosine kinase (LCK) and thereby inhibits phosphorylation of CD3ζ and ζ-chain of T cell receptor–associated protein kinase ...
Source
#1Gael R. Nicolas (Cornell University)H-Index: 2
#2Pamela V. Chang (Cornell University)H-Index: 15
The human intestine harbors an immense, diverse, and critical population of bacteria that has effects on numerous aspects of host physiology, immunity, and disease. Emerging evidence suggests that many of the interactions between the host and the gut microbiota are mediated via the microbial metabolome, or the collection of small-molecule metabolites produced by intestinal bacteria. This review summarizes findings from recent work by focusing on different classes of metabolites produced by the g...
Source
#1Jing Qiu (MPG: Max Planck Society)H-Index: 10
#2Matteo Villa (MPG: Max Planck Society)H-Index: 7
Last. Erika L. Pearce (MPG: Max Planck Society)H-Index: 53
view all 25 authors...
Summary Competition for nutrients like glucose can metabolically restrict T cells and contribute to their hyporesponsiveness during cancer. Metabolic adaptation to the surrounding microenvironment is therefore key for maintaining appropriate cell function. For instance, cancer cells use acetate as a substrate alternative to glucose to fuel metabolism and growth. Here, we show that acetate rescues effector function in glucose-restricted CD8+ T cells. Mechanistically, acetate promotes histone acet...
Source
#1Ashwin N. Skelly (Keio: Keio University)H-Index: 4
#2Yuko Sato (Keio: Keio University)H-Index: 6
Last. Kenya Honda (Keio: Keio University)H-Index: 77
view all 4 authors...
Trillions of microorganisms transit through and reside in the mammalian gastrointestinal tract each day, collectively producing thousands of small molecules and metabolites with local and systemic effects on host physiology. Identifying effector microorganisms that causally affect host phenotype and deciphering the underlying mechanisms have become foci of microbiome research and have begun to enable the development of microbiota-based therapeutics. Two complementary, reductionist approaches hav...
Source
Cited By6
Newest
#1Maik LuuH-Index: 10
#2Alexander Visekruna (University of Marburg)H-Index: 21
The microbiome is a hidden treasure trove comprising various microorganisms that produce a wide range of bioactive molecules. Recent studies provide evidence for the potential impact of microbiota on cancer therapies. Here, we summarize how the molecular interaction of two groups of microbial metabolites with T cells improves immunotherapy for cancer.
Source
#1Nyssa Cullin (DKFZ: German Cancer Research Center)H-Index: 1
#2Camila Azevedo Antunes (DKFZ: German Cancer Research Center)
Last. Eran Elinav (DKFZ: German Cancer Research Center)H-Index: 73
view all 5 authors...
Summary null null The human microbiome constitutes a complex multikingdom community that symbiotically interacts with the host across multiple body sites. Host-microbiome interactions impact multiple physiological processes and a variety of multifactorial disease conditions. In the past decade, microbiome communities have been suggested to influence the development, progression, metastasis formation, and treatment response of multiple cancer types. While causal evidence of microbial impacts on c...
Source
#1Kumbhare SvH-Index: 1
#2Patricia Francis-Lyon (USF: University of San Francisco)H-Index: 3
Last. Sinha RH-Index: 1
view all 12 authors...
Abstract null Background null Diet and lifestyle-related illnesses like obesity and functional gastrointestinal disorders (FGIDs) are rapidly emerging health issues worldwide. Research has focused on addressing FGIDs via in-person cognitive-behavioral therapies and lifestyle modifications focusing on diet modulation and pharmaceutical intervention. However, there is a paucity of research reporting on the effectiveness of digital care based on genome SNP and gut microbiome markers to guide lifest...
Source
#1Ramon M. Rodriguez (International Sleep Products Association)H-Index: 21
#2María L. Saiz (International Sleep Products Association)H-Index: 1
Last. Carlos López-Larrea (International Sleep Products Association)H-Index: 7
view all 4 authors...
The aging process is associated with the accumulation of epigenetic alterations in immune cells, although the origin of these changes is not clear. Understanding this epigenetic drift in the immune system can provide essential information about the progression of the aging process and the immune history of each individual.
Source
#1Alexander Visekruna (University of Marburg)H-Index: 21
#2Maik Luu (University of Marburg)H-Index: 10
During the past decade, researchers have investigated the role of microbiota in health and disease. Recent findings support the hypothesis that commensal bacteria and in particular microbiota-derived metabolites have an impact on development of inflammation and carcinogenesis. Major classes of microbial-derived molecules such as short-chain fatty acids (SCFA) and secondary bile acids (BAs) were shown to have immunomodulatory potential in various autoimmune, inflammatory as well as cancerous dise...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.